Next Article in Journal
Differential Expression of the Sphingolipid Pathway Is Associated with Sensitivity to the PP2A Activator FTY720 in Colorectal Cancer Cell Lines
Next Article in Special Issue
Relation of Baseline Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels and Contrast-Induced Nephropathy following Percutaneous Coronary Intervention among Chronic Kidney Disease Patients
Previous Article in Journal
Risk Factors for Revolving Door in Children and Adolescents with Psychiatric Disorders
Previous Article in Special Issue
GDF-15 Predicts In-Hospital Mortality of Critically Ill Patients with Acute Kidney Injury Requiring Continuous Renal Replacement Therapy: A Multicenter Prospective Study
 
 
Correction published on 17 March 2022, see J. Clin. Med. 2022, 11(6), 1667.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury

1
Samsung Medical Center, Department of Laboratory Medicine and Genetics, School of Medicine, Sungkyunkwan University, Seoul 06351, Korea
2
Biomedical Statistics Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul 06351, Korea
3
Samsung Medical Center, Department of Clinical Pharmacology & Therapeutics, School of Medicine, Sungkyunkwan University, Seoul 06351, Korea
4
Department of Health Science and Technology, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul 06351, Korea
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2021, 10(21), 5005; https://doi.org/10.3390/jcm10215005
Submission received: 8 September 2021 / Revised: 25 October 2021 / Accepted: 25 October 2021 / Published: 27 October 2021 / Corrected: 17 March 2022

Abstract

Acute kidney injury (AKI) is a major contributor to in-hospital morbidity and mortality. Vancomycin, one of the most commonly used antibiotics in a clinical setting, is associated with AKI, with its incidence ranging up to 43%. Despite the high demand, few studies have investigated serum biomarkers to detect vancomycin-induced kidney injury (VIKI). Here, we evaluated the diagnostic value of nine candidate serum biomarkers for VIKI. A total of 23,182 cases referred for vancomycin concentration measurement from January 2018 to December 2019 were screened and 28 subjects with confirmed VIKI were enrolled (VIKI group). Age- and sex- matched control group consisted of 21 subjects who underwent vancomycin therapy without developing VIKI (non-VIKI group), and 23 healthy controls (HC group). The serum concentrations of clusterin, retinol binding protein 4 (RBP4), interleukin-18 (IL-18), tumor necrosis factor receptor 1 (TNF-R1), C-X-C motif chemokine ligand 10 (CXCL10), neutrophil gelatinase-associated lipocalin (NGAL), osteopontin, trefoil factor-3 (TFF3), and cystatin C were compared among the three groups, and their correlations with estimated glomerular filtration rate (eGFR) and diagnostic values for VIKI were assessed. All of the biomarkers except clusterin and RBP4 exhibited significant elevation in the VIKI group. Serum TFF3, cystatin C, TNF-R1, and osteopontin demonstrated an excellent diagnostic value for VIKI (TFF3, area under the curve (AUC) 0.932; cystatin C, AUC 0.917; TNF-R1, AUC 0.866; osteopontin, AUC 0.787); and except osteopontin, a strong negative correlation with eGFR (TFF3, r = −0.71; cystatin C, r = −0.70; TNF-R1, r = −0.60). IL-18, CXCL10, and NGAL showed weak correlation with eGFR and moderate diagnostic value for VIKI. This study tested multiple serum biomarkers for VIKI and showed that serum TFF3, cystatin C, TNF-R1, and osteopontin could efficiently discriminate VIKI patients. Further studies are warranted to clarify the diagnostic value of these biomarkers in VIKI.
Keywords: vancomycin-induced kidney injury; vancomycin; nephrotoxicity; serum biomarker; trefoil factor-3; cystatin C; tumor necrosis factor receptor 1; osteopontin vancomycin-induced kidney injury; vancomycin; nephrotoxicity; serum biomarker; trefoil factor-3; cystatin C; tumor necrosis factor receptor 1; osteopontin

Share and Cite

MDPI and ACS Style

Kim, S.-M.; Lee, H.-S.; Kim, M.-J.; Park, H.-D.; Lee, S.-Y. Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury. J. Clin. Med. 2021, 10, 5005. https://doi.org/10.3390/jcm10215005

AMA Style

Kim S-M, Lee H-S, Kim M-J, Park H-D, Lee S-Y. Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury. Journal of Clinical Medicine. 2021; 10(21):5005. https://doi.org/10.3390/jcm10215005

Chicago/Turabian Style

Kim, Sang-Mi, Hyun-Seung Lee, Min-Ji Kim, Hyung-Doo Park, and Soo-Youn Lee. 2021. "Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury" Journal of Clinical Medicine 10, no. 21: 5005. https://doi.org/10.3390/jcm10215005

APA Style

Kim, S.-M., Lee, H.-S., Kim, M.-J., Park, H.-D., & Lee, S.-Y. (2021). Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury. Journal of Clinical Medicine, 10(21), 5005. https://doi.org/10.3390/jcm10215005

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop